Quality Compounder

556 tickers in this investment thesis
Ranks this page's recent reports by score.
The Hershey Company
HSY·Consumer Staples
A ★★★★Buy
Current$165.61
Target$178.60
Return+7.8%
Nov 1, 2026

Hershey offers durable confectionery brands, strong cash generation, and earnings-recovery potential at an attractive historical cash-flow valuation, but persistent chocolate-volume declines could weaken its pricing power and margins.

Score
78
Haleon plc
HLN·Healthcare
A ★★★★Buy
Current$8.66
Target$9.86
Return+13.9%
Nov 1, 2026

Haleon's trusted consumer healthcare brands and strong cash generation offer attractive long-term value after a sharp repricing, although weak organic sales growth and China's Centrum restrictions could delay recovery.

Score
80
The Cigna Group
CI·Healthcare
A ★★★★Buy
Current$298.23
Target$334.90
Return+12.3%
Nov 1, 2026

Cigna offers strong cash generation, durable healthcare infrastructure, and attractive forward valuation, but PBM contract repricing, regulatory reform, and medical cost inflation threaten its earnings trajectory.

Score
84
Tradeweb Markets Inc.
TW·Financials
A ★★★★Buy
Current$122.54
Target$133.90
Return+9.3%
Nov 1, 2026

Tradeweb combines a durable electronic fixed-income trading network, strong cash generation, and structural market growth, but premium valuation and the $1.97B Trumid acquisition create execution and downside risks.

Score
78
AerCap Holdings N.V.
AER·Industrials
A ★★★★Buy
Current$158.52
Target$186.30
Return+17.5%
Nov 1, 2026

AerCap combines dominant aircraft leasing scale, strong returns on equity, and aggressive share buybacks with an attractive earnings multiple, although cyclical aircraft values and substantial financial leverage remain important risks.

Score
84
Vulcan Materials Company
VMC·Materials
B ★★★Hold
Current$281.25
Target$294.06
Return+4.6%
Nov 1, 2026

Vulcan Materials' scarce quarry assets and resilient pricing power support long-term earnings compounding, but its premium valuation and cyclical construction demand limit the margin of safety.

Score
71
Houlihan Lokey, Inc.
HLI·Financials
A ★★★★Buy
Current$138.00
Target$163.59
Return+18.5%
Nov 1, 2026

Houlihan Lokey combines a durable independent advisory franchise, strong profitability, and M&A recovery potential at a reasonable valuation, although cyclical deal activity and compensation costs remain important earnings risks.

Score
77
AXIS Capital Holdings Limited
AXS·Financials
B ★★★Hold
Current$104.87
Target$121.80
Return+16.1%
Nov 1, 2026

AXIS Capital combines profitable specialty underwriting, strong operating ROE, and substantial buybacks, but catastrophe exposure and a historically elevated price-to-book multiple constrain its margin of safety.

Score
72
Verisk Analytics, Inc.
VRSK·Industrials
A ★★★★Buy
Current$196.30
Target$213.75
Return+8.9%
Nov 1, 2026

Verisk combines a durable insurance data moat, exceptional cash conversion, and a historically discounted valuation, although the unresolved AccuLynx acquisition threatens financial flexibility and capital-allocation returns.

Score
81
Rollins, Inc.
ROL·Consumer Discretionary
A ★★★★Buy
Current$34.66
Target$36.90
Return+6.5%
Nov 1, 2026

Rollins combines recurring pest-control demand, trusted brands, and high returns on capital with a sharply reduced historical valuation, although weak residential customer acquisition and margin pressure may delay an earnings recovery.

Score
76
TowneBank
TOWN·Financials
B ★★★Hold
Current$36.25
Target$39.16
Return+8.0%
Oct 31, 2026

TowneBank offers a profitable Southeastern regional banking franchise with attractive tangible returns and merger-driven expansion, but acquisition dilution, rising problem loans, and uncertain normalized EPS growth limit near-term upside.

Score
70